Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_assertion type Assertion NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_head.
- NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_assertion description "[Fifty-one percent of patients did not express one or more MMR proteins (MMR-) and should be considered Lynch Syndrome carriers (16 patients, group A1); while only 31.2% of them were positive for Amsterdam criteria, 50% had almost another tumor, 37.5% had another colorectal tumor and 68% had relatives with colorectal tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_provenance.
- NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_assertion evidence source_evidence_literature NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_provenance.
- NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_assertion SIO_000772 24533633 NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_provenance.
- NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_assertion wasDerivedFrom befree-20150227 NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_provenance.
- NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_assertion wasGeneratedBy ECO_0000203 NP568832.RAeZ2A6eBDc0RR-2zDuCJH5ZjAt5m1-MXUUTrVfOGuK8c130_provenance.